Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma Article

cited authors

  • Tao, Luwei; Miao, Ruoyu; Mekhail, Tarek; Sun, Jingxin; Meng, Lingbin; Fang, Cheng; Guan, Jian; Jain, Akriti; Du, Yuan; Allen, Amanda; Rzeszutko, Brenda L.; Socinski, Mark A.; Chang, Chung-Che

authors

Publication Date

  • July 1, 2020

webpage

published in

category

keywords

  • Driver mutation
  • Immunotherapy
  • Molecular profiling
  • Precision medicine
  • Prognosis

start page

  • E506

end page

  • E511

volume

  • 22

issue

  • 4